Search hospitals > Quebec > MONTREAL
Royal Victoria Hospital
Claim this profileMONTREAL, Quebec H3A 1A1
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Crohn's Disease
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
141 reported clinical trials
13 medical researchers
Summary
Royal Victoria Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Crohn's Disease, Non-Small Cell Lung Cancer, Leukemia and other specialties. Royal Victoria Hospital is involved with conducting 141 clinical trials across 178 conditions. There are 13 research doctors associated with this hospital, such as Dr. Peter Metrakos, MD, Surgery, Kelly Davison, Thomas Schricker, MD PhD, and Ralph Lattermann, MD PhD.Top PIs
Dr. Peter Metrakos, MD, SurgeryRoyal Victoria Hospital1 year of reported clinical research
Studies Liver Dysfunction
Studies Liver Regeneration
5 reported clinical trials
8 drugs studied
Kelly DavisonThe Research Institute of the McGill University11 years of reported clinical research
Studies Lymphoma
Studies Hodgkin's Lymphoma
4 reported clinical trials
10 drugs studied
Thomas Schricker, MD PhDRoyal Victoria Hospital, McGill University Health Centre5 years of reported clinical research
Studies Cardiac Surgery
Studies Surgical Site Infection
3 reported clinical trials
6 drugs studied
Ralph Lattermann, MD PhDRoyal Victoria Hospital, McGill University Health Centre5 years of reported clinical research
Studies Surgical Site Infection
Studies Liver Failure
2 reported clinical trials
5 drugs studied
Clinical Trials running at Royal Victoria Hospital
Hepatitis C
Surgical Site Infection
Infections
Hepatitis A
Hepatitis
Cancer
Adenocarcinoma
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Small Cell Lung Cancer
Glecaprevir/Pibrentasvir (GLE/PIB)
for Acute Hepatitis C
Hepatitis C Virus (HCV) infection is a global health problem. HCV mainly affects liver cells and causes the liver to become inflamed and damaged. This study will evaluate how safe and effective glecaprevir/pibrentasvir (GLE/PIB) is in adult and adolescent participants with acute HCV infection. GLE/PIB is an approved drug for the treatment of chronic HCV. Around 283 participants at least 12 years of age with acute HCV Infection will be enrolled in approximately 70 sites worldwide. Participants will receive oral tablets of GLE/PIB once daily (QD) for 8 weeks and will be followed for 12 weeks after the end of treatment. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, monitoring for side effects and completing questionnaires.
Recruiting2 awards Phase 31 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Royal Victoria Hospital?
Royal Victoria Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Crohn's Disease, Non-Small Cell Lung Cancer, Leukemia and other specialties. Royal Victoria Hospital is involved with conducting 141 clinical trials across 178 conditions. There are 13 research doctors associated with this hospital, such as Dr. Peter Metrakos, MD, Surgery, Kelly Davison, Thomas Schricker, MD PhD, and Ralph Lattermann, MD PhD.